Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups

Baris Gencer, Alon Eisen, David Berger, Francesco Nordio, Sabina A. Murphy, Laura T. Grip, Cathy Chen, Hans Lanz, Christian T. Ruff, Elliott M. Antman, Eugene Braunwald, Robert P. Giugliano*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Keyphrases